Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent (Q33355508)
Jump to navigation
Jump to search
scientific article published on November 15, 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent |
scientific article published on November 15, 1992 |
Statements
1 reference
Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent (English)
1 reference
M. Andreeff
R. Stone
J. Michaeli
C. W. Young
W. P. Tong
H. Sogoloff
T. Ervin
D. Kufe
R. A. Rifkind
P. A. Marks
1 November 1992
1 reference
15 November 1992